Paeoniflorin inhibits macrophage-mediated lung cancer metastasis

Alternatively activated macrophages are more frequently involved in tumor growth, angiogenesis, and immunosuppression. A previous study showed that paeoniflorin, the major active constituent of Paeonia lactiflora Pallas, can inhibit tumor growth and lung metastases of Lewis lung tumor-bearing mice....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chinese journal of natural medicines 2015-12, Vol.13 (12), p.925-932
Hauptverfasser: WU, Qi, CHEN, Gang-Ling, LI, Ya-Juan, CHEN, Yang, LIN, Fang-Zhen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 932
container_issue 12
container_start_page 925
container_title Chinese journal of natural medicines
container_volume 13
creator WU, Qi
CHEN, Gang-Ling
LI, Ya-Juan
CHEN, Yang
LIN, Fang-Zhen
description Alternatively activated macrophages are more frequently involved in tumor growth, angiogenesis, and immunosuppression. A previous study showed that paeoniflorin, the major active constituent of Paeonia lactiflora Pallas, can inhibit tumor growth and lung metastases of Lewis lung tumor-bearing mice. This study tried to investigate whether paeoniflorin inhibited lung cancer metastasis by inhibiting the alternative activation ofmacrophages (M2 macrophage). Using a viability assay, the cytotoxicity of paeoniflorin on Lewis lung cancer cells and peritoneal macrophages were investigated. In vitro scratch wound and in vivo lung metastasis experiments were used to test the ability to inhibit the migration of paeoniflorin and the function of M2 macrophages. Flow cytometry was performed to test the cell cycle of Lewis lung cancer cells, and to test the M2 macrophages in peritoneal maerophages and subcutaneous transplantable rumor. It was found that paeoniflorin showed no inhibitory effect on the growth of Lewis lung cancer ceils and peritoneal macrophages of mouse in vitro. Paeoniflorin could attenuate the migration of LLC stimulated by alternatively activated macrophages (stimulated for 24 h and 48 h, paeoniflorin 1, 3, 10, 30, 100 μmol·L^-1, P 〈 0.01 or P 〈 0.05 vs control group). Paeoniflorin could decrease the cell populations at S phases (paeoniflorin 10, 30, 100 μmol·L^-1, P 〈 0.05 vs control group) and increase the cell populations at G0-G1 phases of Lewis lung cancer cells (paeoniflorin 100 μmol·L^-1, P 〈 0.05 vs control group) and reduce the numbers of M2 macrophages in peritoneal macrophages induced by IL-4 (paeoniflorin 1, 3, 10, 30, 100 μmol·L^-1, P 〈 0.01 vs Control group). Paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft and decrease the numbers of M2 macrophages in subcutaneous xenograft tumour in vivo (paeoniflorin 20, 40 mg·kg^-1, P 〈 0.01 vs control group). These results suggest that paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenografl partly through inhibiting the alternative activation of macrophages.
doi_str_mv 10.1016/S1875-5364(15)30098-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1753010416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>667181683</cqvip_id><els_id>S1875536415300984</els_id><sourcerecordid>1753010416</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-4153d8acfeb2e0e1195ed3221dfeabffcabfa3c28ca0e2dea4c2541c9da6cdc13</originalsourceid><addsrcrecordid>eNqFkFtLAzEQhYMoWrQ_QVl80ofVTG67-6Qi3kBQUJ9DNpltA3upyVbw35va2lfDkMBwZk7OR8gx0AugoC7foCxkLrkSZyDPOaVVmYsdMtm2d8mE0UrmqirkAZnG6GvKeDpFAfvkgKmCQQEwIdevBofeN-0QfJ_5fu5rP8asMzYMi7mZYd6h82ZEl7XLfpZZ01sMWYejial8PCJ7jWkjTjfvIfm4v3u_fcyfXx6ebm-ecyuEGHMBkrvS2AZrhhQBKomOMwauQVM3jU2X4ZaV1lBkDo2wTAqwlTPKOgv8kJyt9y7C8LnEOOrOR4tta3ocllFDITkFKkAlqVxLU4YYAzZ6EXxnwrcGqlf89C8_vQKlQepfflqkuZONxbJOqbdTf7SS4GotwBT0y2PQ0XpMQJwPaEftBv-vxenma_Ohn336frZ1UaqAElTJ-Q-kAozT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1753010416</pqid></control><display><type>article</type><title>Paeoniflorin inhibits macrophage-mediated lung cancer metastasis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Alma/SFX Local Collection</source><creator>WU, Qi ; CHEN, Gang-Ling ; LI, Ya-Juan ; CHEN, Yang ; LIN, Fang-Zhen</creator><creatorcontrib>WU, Qi ; CHEN, Gang-Ling ; LI, Ya-Juan ; CHEN, Yang ; LIN, Fang-Zhen</creatorcontrib><description>Alternatively activated macrophages are more frequently involved in tumor growth, angiogenesis, and immunosuppression. A previous study showed that paeoniflorin, the major active constituent of Paeonia lactiflora Pallas, can inhibit tumor growth and lung metastases of Lewis lung tumor-bearing mice. This study tried to investigate whether paeoniflorin inhibited lung cancer metastasis by inhibiting the alternative activation ofmacrophages (M2 macrophage). Using a viability assay, the cytotoxicity of paeoniflorin on Lewis lung cancer cells and peritoneal macrophages were investigated. In vitro scratch wound and in vivo lung metastasis experiments were used to test the ability to inhibit the migration of paeoniflorin and the function of M2 macrophages. Flow cytometry was performed to test the cell cycle of Lewis lung cancer cells, and to test the M2 macrophages in peritoneal maerophages and subcutaneous transplantable rumor. It was found that paeoniflorin showed no inhibitory effect on the growth of Lewis lung cancer ceils and peritoneal macrophages of mouse in vitro. Paeoniflorin could attenuate the migration of LLC stimulated by alternatively activated macrophages (stimulated for 24 h and 48 h, paeoniflorin 1, 3, 10, 30, 100 μmol·L^-1, P 〈 0.01 or P 〈 0.05 vs control group). Paeoniflorin could decrease the cell populations at S phases (paeoniflorin 10, 30, 100 μmol·L^-1, P 〈 0.05 vs control group) and increase the cell populations at G0-G1 phases of Lewis lung cancer cells (paeoniflorin 100 μmol·L^-1, P 〈 0.05 vs control group) and reduce the numbers of M2 macrophages in peritoneal macrophages induced by IL-4 (paeoniflorin 1, 3, 10, 30, 100 μmol·L^-1, P 〈 0.01 vs Control group). Paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft and decrease the numbers of M2 macrophages in subcutaneous xenograft tumour in vivo (paeoniflorin 20, 40 mg·kg^-1, P 〈 0.01 vs control group). These results suggest that paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenografl partly through inhibiting the alternative activation of macrophages.</description><identifier>ISSN: 2095-6975</identifier><identifier>ISSN: 1875-5364</identifier><identifier>EISSN: 1875-5364</identifier><identifier>DOI: 10.1016/S1875-5364(15)30098-4</identifier><identifier>PMID: 26721711</identifier><language>eng</language><publisher>China: Elsevier B.V</publisher><subject>activated ; Alternatively ; Alternatively activated macrophages ; Animals ; cancer ; Cell Movement - drug effects ; Cell Proliferation - drug effects ; Down-Regulation - drug effects ; Female ; Glucosides - administration &amp; dosage ; Humans ; Interleukin-4 - immunology ; Lung ; Lung cancer ; Lung Neoplasms - drug therapy ; Lung Neoplasms - immunology ; Lung Neoplasms - pathology ; Lung Neoplasms - physiopathology ; macrophages ; Macrophages - cytology ; Macrophages - drug effects ; Macrophages - immunology ; Metastasis ; Mice ; Mice, Inbred C57BL ; Monoterpenes - administration &amp; dosage ; Neoplasm Metastasis ; Paeonia - chemistry ; Paeoniflorin ; Tumor-associated ; Tumor-associated macrophages</subject><ispartof>Chinese journal of natural medicines, 2015-12, Vol.13 (12), p.925-932</ispartof><rights>2015 China Pharmaceutical University</rights><rights>Copyright © 2015 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-4153d8acfeb2e0e1195ed3221dfeabffcabfa3c28ca0e2dea4c2541c9da6cdc13</citedby><cites>FETCH-LOGICAL-c444t-4153d8acfeb2e0e1195ed3221dfeabffcabfa3c28ca0e2dea4c2541c9da6cdc13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/86968X/86968X.jpg</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S1875-5364(15)30098-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26721711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WU, Qi</creatorcontrib><creatorcontrib>CHEN, Gang-Ling</creatorcontrib><creatorcontrib>LI, Ya-Juan</creatorcontrib><creatorcontrib>CHEN, Yang</creatorcontrib><creatorcontrib>LIN, Fang-Zhen</creatorcontrib><title>Paeoniflorin inhibits macrophage-mediated lung cancer metastasis</title><title>Chinese journal of natural medicines</title><addtitle>Chinese JOurnal of Natural Medicines</addtitle><description>Alternatively activated macrophages are more frequently involved in tumor growth, angiogenesis, and immunosuppression. A previous study showed that paeoniflorin, the major active constituent of Paeonia lactiflora Pallas, can inhibit tumor growth and lung metastases of Lewis lung tumor-bearing mice. This study tried to investigate whether paeoniflorin inhibited lung cancer metastasis by inhibiting the alternative activation ofmacrophages (M2 macrophage). Using a viability assay, the cytotoxicity of paeoniflorin on Lewis lung cancer cells and peritoneal macrophages were investigated. In vitro scratch wound and in vivo lung metastasis experiments were used to test the ability to inhibit the migration of paeoniflorin and the function of M2 macrophages. Flow cytometry was performed to test the cell cycle of Lewis lung cancer cells, and to test the M2 macrophages in peritoneal maerophages and subcutaneous transplantable rumor. It was found that paeoniflorin showed no inhibitory effect on the growth of Lewis lung cancer ceils and peritoneal macrophages of mouse in vitro. Paeoniflorin could attenuate the migration of LLC stimulated by alternatively activated macrophages (stimulated for 24 h and 48 h, paeoniflorin 1, 3, 10, 30, 100 μmol·L^-1, P 〈 0.01 or P 〈 0.05 vs control group). Paeoniflorin could decrease the cell populations at S phases (paeoniflorin 10, 30, 100 μmol·L^-1, P 〈 0.05 vs control group) and increase the cell populations at G0-G1 phases of Lewis lung cancer cells (paeoniflorin 100 μmol·L^-1, P 〈 0.05 vs control group) and reduce the numbers of M2 macrophages in peritoneal macrophages induced by IL-4 (paeoniflorin 1, 3, 10, 30, 100 μmol·L^-1, P 〈 0.01 vs Control group). Paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft and decrease the numbers of M2 macrophages in subcutaneous xenograft tumour in vivo (paeoniflorin 20, 40 mg·kg^-1, P 〈 0.01 vs control group). These results suggest that paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenografl partly through inhibiting the alternative activation of macrophages.</description><subject>activated</subject><subject>Alternatively</subject><subject>Alternatively activated macrophages</subject><subject>Animals</subject><subject>cancer</subject><subject>Cell Movement - drug effects</subject><subject>Cell Proliferation - drug effects</subject><subject>Down-Regulation - drug effects</subject><subject>Female</subject><subject>Glucosides - administration &amp; dosage</subject><subject>Humans</subject><subject>Interleukin-4 - immunology</subject><subject>Lung</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - immunology</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - physiopathology</subject><subject>macrophages</subject><subject>Macrophages - cytology</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - immunology</subject><subject>Metastasis</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Monoterpenes - administration &amp; dosage</subject><subject>Neoplasm Metastasis</subject><subject>Paeonia - chemistry</subject><subject>Paeoniflorin</subject><subject>Tumor-associated</subject><subject>Tumor-associated macrophages</subject><issn>2095-6975</issn><issn>1875-5364</issn><issn>1875-5364</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkFtLAzEQhYMoWrQ_QVl80ofVTG67-6Qi3kBQUJ9DNpltA3upyVbw35va2lfDkMBwZk7OR8gx0AugoC7foCxkLrkSZyDPOaVVmYsdMtm2d8mE0UrmqirkAZnG6GvKeDpFAfvkgKmCQQEwIdevBofeN-0QfJ_5fu5rP8asMzYMi7mZYd6h82ZEl7XLfpZZ01sMWYejial8PCJ7jWkjTjfvIfm4v3u_fcyfXx6ebm-ecyuEGHMBkrvS2AZrhhQBKomOMwauQVM3jU2X4ZaV1lBkDo2wTAqwlTPKOgv8kJyt9y7C8LnEOOrOR4tta3ocllFDITkFKkAlqVxLU4YYAzZ6EXxnwrcGqlf89C8_vQKlQepfflqkuZONxbJOqbdTf7SS4GotwBT0y2PQ0XpMQJwPaEftBv-vxenma_Ohn336frZ1UaqAElTJ-Q-kAozT</recordid><startdate>20151201</startdate><enddate>20151201</enddate><creator>WU, Qi</creator><creator>CHEN, Gang-Ling</creator><creator>LI, Ya-Juan</creator><creator>CHEN, Yang</creator><creator>LIN, Fang-Zhen</creator><general>Elsevier B.V</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20151201</creationdate><title>Paeoniflorin inhibits macrophage-mediated lung cancer metastasis</title><author>WU, Qi ; CHEN, Gang-Ling ; LI, Ya-Juan ; CHEN, Yang ; LIN, Fang-Zhen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-4153d8acfeb2e0e1195ed3221dfeabffcabfa3c28ca0e2dea4c2541c9da6cdc13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>activated</topic><topic>Alternatively</topic><topic>Alternatively activated macrophages</topic><topic>Animals</topic><topic>cancer</topic><topic>Cell Movement - drug effects</topic><topic>Cell Proliferation - drug effects</topic><topic>Down-Regulation - drug effects</topic><topic>Female</topic><topic>Glucosides - administration &amp; dosage</topic><topic>Humans</topic><topic>Interleukin-4 - immunology</topic><topic>Lung</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - immunology</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - physiopathology</topic><topic>macrophages</topic><topic>Macrophages - cytology</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - immunology</topic><topic>Metastasis</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Monoterpenes - administration &amp; dosage</topic><topic>Neoplasm Metastasis</topic><topic>Paeonia - chemistry</topic><topic>Paeoniflorin</topic><topic>Tumor-associated</topic><topic>Tumor-associated macrophages</topic><toplevel>online_resources</toplevel><creatorcontrib>WU, Qi</creatorcontrib><creatorcontrib>CHEN, Gang-Ling</creatorcontrib><creatorcontrib>LI, Ya-Juan</creatorcontrib><creatorcontrib>CHEN, Yang</creatorcontrib><creatorcontrib>LIN, Fang-Zhen</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Chinese journal of natural medicines</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WU, Qi</au><au>CHEN, Gang-Ling</au><au>LI, Ya-Juan</au><au>CHEN, Yang</au><au>LIN, Fang-Zhen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Paeoniflorin inhibits macrophage-mediated lung cancer metastasis</atitle><jtitle>Chinese journal of natural medicines</jtitle><addtitle>Chinese JOurnal of Natural Medicines</addtitle><date>2015-12-01</date><risdate>2015</risdate><volume>13</volume><issue>12</issue><spage>925</spage><epage>932</epage><pages>925-932</pages><issn>2095-6975</issn><issn>1875-5364</issn><eissn>1875-5364</eissn><abstract>Alternatively activated macrophages are more frequently involved in tumor growth, angiogenesis, and immunosuppression. A previous study showed that paeoniflorin, the major active constituent of Paeonia lactiflora Pallas, can inhibit tumor growth and lung metastases of Lewis lung tumor-bearing mice. This study tried to investigate whether paeoniflorin inhibited lung cancer metastasis by inhibiting the alternative activation ofmacrophages (M2 macrophage). Using a viability assay, the cytotoxicity of paeoniflorin on Lewis lung cancer cells and peritoneal macrophages were investigated. In vitro scratch wound and in vivo lung metastasis experiments were used to test the ability to inhibit the migration of paeoniflorin and the function of M2 macrophages. Flow cytometry was performed to test the cell cycle of Lewis lung cancer cells, and to test the M2 macrophages in peritoneal maerophages and subcutaneous transplantable rumor. It was found that paeoniflorin showed no inhibitory effect on the growth of Lewis lung cancer ceils and peritoneal macrophages of mouse in vitro. Paeoniflorin could attenuate the migration of LLC stimulated by alternatively activated macrophages (stimulated for 24 h and 48 h, paeoniflorin 1, 3, 10, 30, 100 μmol·L^-1, P 〈 0.01 or P 〈 0.05 vs control group). Paeoniflorin could decrease the cell populations at S phases (paeoniflorin 10, 30, 100 μmol·L^-1, P 〈 0.05 vs control group) and increase the cell populations at G0-G1 phases of Lewis lung cancer cells (paeoniflorin 100 μmol·L^-1, P 〈 0.05 vs control group) and reduce the numbers of M2 macrophages in peritoneal macrophages induced by IL-4 (paeoniflorin 1, 3, 10, 30, 100 μmol·L^-1, P 〈 0.01 vs Control group). Paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft and decrease the numbers of M2 macrophages in subcutaneous xenograft tumour in vivo (paeoniflorin 20, 40 mg·kg^-1, P 〈 0.01 vs control group). These results suggest that paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenografl partly through inhibiting the alternative activation of macrophages.</abstract><cop>China</cop><pub>Elsevier B.V</pub><pmid>26721711</pmid><doi>10.1016/S1875-5364(15)30098-4</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2095-6975
ispartof Chinese journal of natural medicines, 2015-12, Vol.13 (12), p.925-932
issn 2095-6975
1875-5364
1875-5364
language eng
recordid cdi_proquest_miscellaneous_1753010416
source MEDLINE; ScienceDirect Journals (5 years ago - present); Alma/SFX Local Collection
subjects activated
Alternatively
Alternatively activated macrophages
Animals
cancer
Cell Movement - drug effects
Cell Proliferation - drug effects
Down-Regulation - drug effects
Female
Glucosides - administration & dosage
Humans
Interleukin-4 - immunology
Lung
Lung cancer
Lung Neoplasms - drug therapy
Lung Neoplasms - immunology
Lung Neoplasms - pathology
Lung Neoplasms - physiopathology
macrophages
Macrophages - cytology
Macrophages - drug effects
Macrophages - immunology
Metastasis
Mice
Mice, Inbred C57BL
Monoterpenes - administration & dosage
Neoplasm Metastasis
Paeonia - chemistry
Paeoniflorin
Tumor-associated
Tumor-associated macrophages
title Paeoniflorin inhibits macrophage-mediated lung cancer metastasis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T12%3A28%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Paeoniflorin%20inhibits%20macrophage-mediated%20lung%20cancer%20metastasis&rft.jtitle=Chinese%20journal%20of%20natural%20medicines&rft.au=WU,%20Qi&rft.date=2015-12-01&rft.volume=13&rft.issue=12&rft.spage=925&rft.epage=932&rft.pages=925-932&rft.issn=2095-6975&rft.eissn=1875-5364&rft_id=info:doi/10.1016/S1875-5364(15)30098-4&rft_dat=%3Cproquest_cross%3E1753010416%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1753010416&rft_id=info:pmid/26721711&rft_cqvip_id=667181683&rft_els_id=S1875536415300984&rfr_iscdi=true